Article
The EGF receptor Hokey-Cokey.
Cancer cell - 1 Mar 2007
Niculescu-Duvaz Dan, Whittaker Steven, Springer Caroline, Marais Richard
Abstract excerpt
In cancer, the epidermal growth factor (EGF) receptor (EGFR) can be activated by mutations that disrupt the inactive conformation and allow the active conformation to predominate. Structural studies have elucidated the molecular events that lead to EGFR activation and shown that small-molecule anti-EGFR drugs can bind to either the inactive or the active conformation of the kinase domain. In this issue of Cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
